Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Oct;22(4):672–677. doi: 10.1128/aac.22.4.672

Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid.

A Iravani, G A Richard
PMCID: PMC183812  PMID: 7181477

Abstract

A 10-day course of amoxicillin (250 mg)-potassium clavulanate (125 mg) was administered three times daily to 116 female college students with urinary tract infections. All of the bacterial isolates from these patients were susceptible to amoxicillin-potassium clavulanate in vitro; only 81.0% were susceptible to amoxicillin alone. Evaluations at 1 week after completion of this course showed that clinical and bacteriological cures had been achieved in 96.9% of those who completed therapy. Cures were sustained in 85.6% of the patients examined at 4 weeks after the end of therapy. Therapeutic responses were comparable, irrespective of the results of antibody-coated bacteria tests. All strains of Enterobacteriaceae isolated from the rectal and urogenital sites at 1 week after therapy were susceptible to amoxicillin-potassium clavulanate. The proportion of fecal Escherichia coli resistant to amoxicillin alone increased from 13.3% before therapy to 35.6% at 1 week after therapy. Adverse drug reactions consisted of gastrointestinal symptoms (9.8%) and rashes (4.1%). Sixteen patients (14.2%) developed symptomatic candida vaginitis by 1 week after therapy.

Full text

PDF
672

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ball A. P., Geddes A. M., Davey P. G., Farrell I. D., Brookes G. R. Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study. Lancet. 1980 Mar 22;1(8169):620–623. doi: 10.1016/s0140-6736(80)91118-6. [DOI] [PubMed] [Google Scholar]
  2. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  3. Bear D. M., Turck M., Petersdorf R. G. Ampicillin. Med Clin North Am. 1970 Sep;54(5):1145–1159. [PubMed] [Google Scholar]
  4. Brogeden R. N., Speight T. M., Avery G. S. Amoxycillin: A review of its antibacterial and pharmacokinietic properties and therapeutic use. Drugs. 1975;9(2):88–140. doi: 10.2165/00003495-197509020-00002. [DOI] [PubMed] [Google Scholar]
  5. CUTLER S. J., EDERER F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958 Dec;8(6):699–712. doi: 10.1016/0021-9681(58)90126-7. [DOI] [PubMed] [Google Scholar]
  6. Durkin J. P., Viswanatha T. Clavulanic acid inhibition of beta-lactamase I from Bacillus cereus 569/H. J Antibiot (Tokyo) 1978 Nov;31(11):1162–1169. doi: 10.7164/antibiotics.31.1162. [DOI] [PubMed] [Google Scholar]
  7. FREEMAN G. H., HALTON J. H. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika. 1951 Jun;38(1-2):141–149. [PubMed] [Google Scholar]
  8. Goldstein F. W., Kitzis M. D., Acar J. F. Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections. J Antimicrob Chemother. 1979 Nov;5(6):705–709. doi: 10.1093/jac/5.6.705. [DOI] [PubMed] [Google Scholar]
  9. Grüneberg R. N. Susceptibility of urinary pathogens to various antimicrobial substances: a four-year study. J Clin Pathol. 1976 Apr;29(4):292–295. doi: 10.1136/jcp.29.4.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Iravani A., Richard G. A., Baer H., Fennell R. Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women. Antimicrob Agents Chemother. 1981 Apr;19(4):598–604. doi: 10.1128/aac.19.4.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Iravani A., Richard G. A., Baer H. Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora. Antimicrob Agents Chemother. 1981 May;19(5):842–850. doi: 10.1128/aac.19.5.842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jordan P. A., Iravani A., Richard G. A., Baer H. Urinary tract infection caused by Staphylococcus saprophyticus. J Infect Dis. 1980 Oct;142(4):510–515. doi: 10.1093/infdis/142.4.510. [DOI] [PubMed] [Google Scholar]
  13. Kunin C. M. A ten-year study of bacteriuria in schoolgirls: final report of bacteriologic, urologic, and epidemiologic findings. J Infect Dis. 1970 Nov;122(5):382–393. doi: 10.1093/infdis/122.5.382. [DOI] [PubMed] [Google Scholar]
  14. Matsuura M., Nakazawa H., Hashimoto T., Mitsuhashi S. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains. Antimicrob Agents Chemother. 1980 Jun;17(6):908–911. doi: 10.1128/aac.17.6.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Minami S., Yotsuji A., Inoue M., Mitsuhashi S. Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae. Antimicrob Agents Chemother. 1980 Sep;18(3):382–385. doi: 10.1128/aac.18.3.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Neringer R., Strömberg A. A comparison of the side-effects of amoxycillin and pivampicillin. Scand J Infect Dis. 1980;12(2):133–135. doi: 10.3109/inf.1980.12.issue-2.11. [DOI] [PubMed] [Google Scholar]
  17. Neu H. C., Fu K. P. Clavulanic acid, a novel inhibitor of beta-lactamases. Antimicrob Agents Chemother. 1978 Nov;14(5):650–655. doi: 10.1128/aac.14.5.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nyström B. Patterns of antibiotic sensitivity in bacteria isolated from hospital in-patients. A study at the Karolinska Hospital, 1969. Scand J Infect Dis. 1971;3(3):229–233. doi: 10.3109/inf.1971.3.issue-3.09. [DOI] [PubMed] [Google Scholar]
  19. Richard G. A., Iravani A., LeFrock J. L., Mogabgab W. Bacampicillin vs. amoxicillin for treatment of acute infections of the urinary tract. Rev Infect Dis. 1981 Jan-Feb;3(1):159–165. doi: 10.1093/clinids/3.1.159. [DOI] [PubMed] [Google Scholar]
  20. Shaw E. J., Datta N., Jones G., Marr F. M., Froud W. J. Effect of stay in hospital and oral chemotherapy on the antibiotic sensitivity of bowel coliforms. J Hyg (Lond) 1973 Sep;71(3):529–534. doi: 10.1017/s0022172400046519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. TURCK M., PETERSDORF R. G. The epidemiology of nonenteric Escherichia coli infections: prevalence of serological groups. J Clin Invest. 1962 Sep;41:1760–1765. doi: 10.1172/JCI104635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Thomas V., Shelokov A., Forland M. Antibody-coated bacteria in the urine and the site of urinary-tract infection. N Engl J Med. 1974 Mar 14;290(11):588–590. doi: 10.1056/NEJM197403142901102. [DOI] [PubMed] [Google Scholar]
  23. Wise P. J., Neu H. C. Experience with amoxicillin: an overall summary of clinical trials in the United States. J Infect Dis. 1974 Jun;129(0):suppl–suppl:S271. doi: 10.1093/infdis/129.supplement_2.s266. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES